GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Gross Profit

Hamilton Thorne (TSX:HTL) Gross Profit : C$47.82 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Gross Profit?

Hamilton Thorne's gross profit for the three months ended in Mar. 2024 was C$13.76 Mil. Hamilton Thorne's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was C$47.82 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Hamilton Thorne's gross profit for the three months ended in Mar. 2024 was C$13.76 Mil. Hamilton Thorne's Revenue for the three months ended in Mar. 2024 was C$26.25 Mil. Therefore, Hamilton Thorne's Gross Margin % for the quarter that ended in Mar. 2024 was 52.42%.

Hamilton Thorne had a gross margin of 52.42% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Hamilton Thorne was 65.27%. The lowest was 49.98%. And the median was 55.16%.

Warning Sign:

Hamilton Thorne Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.3%.


Hamilton Thorne Gross Profit Historical Data

The historical data trend for Hamilton Thorne's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Gross Profit Chart

Hamilton Thorne Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.06 26.12 33.55 39.51 45.42

Hamilton Thorne Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.56 11.35 10.39 12.33 13.76

Competitive Comparison of Hamilton Thorne's Gross Profit

For the Medical Devices subindustry, Hamilton Thorne's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamilton Thorne's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's Gross Profit distribution charts can be found below:

* The bar in red indicates where Hamilton Thorne's Gross Profit falls into.



Hamilton Thorne Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Hamilton Thorne's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=90.189 - 44.774
=45.42

Hamilton Thorne's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=26.25 - 12.491
=13.76

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$47.82 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Hamilton Thorne's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=13.76 / 26.25
=52.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Hamilton Thorne  (TSX:HTL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Hamilton Thorne had a gross margin of 52.42% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Hamilton Thorne Gross Profit Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamilton Thorne (TSX:HTL) Business Description

Traded in Other Exchanges
Address
100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Executives
Robert J Potter Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines